Search Grant Opportunities

Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)?

ID: RFA-AG-24-038 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate the use of existing biospecimens and datasets (i.e., secondary analysis) which will increase our understanding of the clinical significance of clonal hematopoiesis (CH) mutations, their causality, directionality, relationships with different human aging phenotypes, and the underlying biological mechanisms.
Background
The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate the use of existing biospecimens and datasets (i.e., secondary analysis) which will increase our understanding of the clinical significance of clonal hematopoiesis (CH) mutations, their causality, directionality, relationships with different human aging phenotypes, and the underlying biological mechanisms. CH is a condition related to aging wherein clonal expansion of hematopoietic cells driven by somatic mutations increases markedly with age in humans.

Grant Details
The NOFO will use the R01 grant mechanism to support studies using sequencing-based analyses of biospecimens from epidemiological cohorts with extensive physiologic, genetic, and omics data to assess the clinical significance of somatic mutations for a variety of age-related outcomes. New data and specimen collection to supplement existing datasets is allowed when essential for addressing the specific aims of the proposed study. Studies should consider both potential deleterious and protective effects of CH mutations and the molecular mechanisms underpinning pleiotropic effects of CH in aging. Analysis of biospecimens from clinical trials focused on age-related outcomes is also strongly encouraged to assess and clarify the relationship of CH to treatment effects and to evaluate the clinical utility of CH screening in clinical practice for risk prediction and prognosis for age-related disease.

Eligibility Requirements
Eligible applicants include Higher Education Institutions, Public/State Controlled Institutions of Higher Education, Private Institutions of Higher Education, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education), Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education), For-Profit Organizations (including Small Businesses), Local Governments, State Governments, County Governments, City or Township Governments, Special District Governments, Indian/Native American Tribal Governments (Federally Recognized), Indian/Native American Tribal Governments (Other than Federally Recognized), Federal Governments, U.S. Territory or Possession, Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (other than Federally recognized tribal governments), Faith-based or Community-based Organizations.

Period of Performance
The period of performance will be determined by the scope of the proposed project but should not exceed 5 years.

Grant Value
NIA intends to commit $5 million in fiscal year 2024 to fund up to 4 applications. Application budgets are limited to up to $1 million in direct costs.

Overview

Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 5/17/23 the National Institutes of Health posted grant opportunity RFA-AG-24-038 for Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)?. The grant will be issued under grant program 93.866 Aging Research.

Timing

Posted Date
May 17, 2023, 12:00 a.m. EDT
Closing Date
Oct. 23, 2023, 12:00 a.m. EDT Past Due
Last Updated
May 17, 2023, 9:48 a.m. EDT
Version
1
Archive Date
Nov. 28, 2023

Eligibility

Eligible Applicants
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
City or township governments
Private institutions of higher education
For profit organizations other than small businesses
County governments
Small businesses
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$1,000,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-038.html

Documents

Posted documents for RFA-AG-24-038

Opportunity Assistant


AI Analysis

AI Generate

Grant Awards

Grants awarded through RFA-AG-24-038

Incumbent or Similar Grants

Grants similar to RFA-AG-24-038

Similar Active Opportunities

Open grant opportunities similar to RFA-AG-24-038

Experts for Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)?

Recommended subject matter experts available for hire